Your browser doesn't support javascript.
loading
Transient Receptor Potential Vanilloid (TRPV4) channel inhibition: A novel promising approach for the treatment of lung diseases.
Kumar, Mohit; Zaman, Md Kamaruz; Das, Sanghita; Goyary, Danswrang; Pathak, Manash Pratim; Chattopadhyay, Pronobesh.
Afiliación
  • Kumar M; Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur, Assam 784001, India; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004, India.
  • Zaman MK; Department of Pharmaceutical Sciences, Dibrugarh University, Dibrugarh, Assam 786004, India.
  • Das S; Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur, Assam 784001, India; Pharmaceutical & Fine Chemical Division, Department of Chemical Technology, University of Calcutta, Kolkata, West Bengal 700073, India.
  • Goyary D; Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur, Assam 784001, India.
  • Pathak MP; Faculty of Pharmaceutical Science, Assam down town University, Guwahati, Assam 781026, India. Electronic address: manashpharma@rediffmail.com.
  • Chattopadhyay P; Division of Pharmaceutical Technology, Defence Research Laboratory, Tezpur, Assam 784001, India. Electronic address: chattopadhyay.drl@gmail.com.
Biomed Pharmacother ; 163: 114861, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37178575

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Canales de Potencial de Receptor Transitorio / Hipertensión Pulmonar Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Canales de Potencial de Receptor Transitorio / Hipertensión Pulmonar Límite: Humans Idioma: En Revista: Biomed Pharmacother Año: 2023 Tipo del documento: Article País de afiliación: India Pais de publicación: Francia